860 Uric acid is the main component of kidney stones in patients with autosomal dominant polycystic kidney disease (ADPKD) – a study based on stone composition, morphology and infrared spectophotometry analysis

2012 ◽  
Vol 11 (1) ◽  
pp. e860-e860a ◽  
Author(s):  
I. Nikolov ◽  
O. Ivanovski ◽  
M. Daudon ◽  
A. Sikole ◽  
B. Knebelman
2021 ◽  
Vol 8 ◽  
pp. 205435812110002
Author(s):  
Vinusha Kalatharan ◽  
Blayne Welk ◽  
Danielle M. Nash ◽  
Stephanie N. Dixon ◽  
Justin Slater ◽  
...  

Background: There is a perception that patients with autosomal dominant polycystic kidney disease (ADPKD) are more likely to develop kidney stones than the general population. Objective: To compare the rate of hospital encounter with kidney stones and the rate of stone interventions between patients with and without ADPKD. Design: Retrospective cohort study. Setting: Ontario, Canada. Patients: Patients with and without ADPKD who had a prior hospital encounter between 2002 and 2016. Measurements: Rate of hospital encounter with kidney stones and rate of stone intervention. Methods: We used inverse probability exposure weighting based on propensity scores to balance baseline indicators of health between patients with and without ADPKD. We followed each patient until death, emigration, outcomes, or March 31, 2017. We used a Cox proportional hazards model to compare event rates between the two groups. Results: Patients with ADPKD were at higher risk of hospital encounter with stones compared with patients without ADPKD (81 patients of 2094 with ADPKD [3.8%] vs 60 patients of 1902 without ADPKD [3.2%]; 8.9 vs 5.1 events per 1000 person-years; hazard ratio 1.6 [95% CI, 1.3-2.1]). ADPKD was not associated with a higher risk of stone intervention (49 of 2094 [2.3%] vs 47 of 1902 [2.4%]; 5.3 vs 3.9 events per 1000 person-years; hazard ratio 1.2 [95% CI = 0.9-1.3]). Limitations: We did not have information on kidney stone events outside of the hospital. There is a possibility of residual confounding. Conclusion: ADPKD was a significant risk factor for hospital encounters with kidney stones.


2021 ◽  
Vol 6 (4) ◽  
pp. S128
Author(s):  
A. Zalfeni ◽  
D. Zellema ◽  
W. Sahtout ◽  
M. Hadj Ibrahim ◽  
A. Azzabi ◽  
...  

1990 ◽  
Vol 89 (1) ◽  
pp. 49-52 ◽  
Author(s):  
William D. Kaehny ◽  
Douglas J. Tangel ◽  
Ann M. Johnson ◽  
William J. Kimberling ◽  
Robert W. Schrier ◽  
...  

2012 ◽  
Vol 28 (2) ◽  
pp. 380-385 ◽  
Author(s):  
Imed Helal ◽  
Kim McFann ◽  
Berenice Reed ◽  
Xiang-Dong Yan ◽  
Robert W. Schrier ◽  
...  

2013 ◽  
Vol 123 (3-4) ◽  
pp. 157-164 ◽  
Author(s):  
Ismail Kocyigit ◽  
Mahmut Ilker Yilmaz ◽  
Ozcan Orscelik ◽  
Murat Hayri Sipahioglu ◽  
Aydin Unal ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document